OBJECTIVE: To estimate the incidence and mortality rates for pancreatic cancer in China. METHODS: After checking and reviewing the cancer registry data in 2009 from 72 cancer registry centers, we divided cancer registry areas into urban and rural areas. Incidence/mortality rates, age-specific incidence/mortality rates, age- standardized incidence/mortality rates, proportions, and cumulative incidence/mortality rates for pancreatic cancer were calculated. RESULTS: The total number of newly diagnosed pancreatic cancer cases and deaths in 2009 were 6,220 and 5,650, respectively. The crude incidence rate in all cancer registry areas was 7.28/100,000 (males 8.24, females 6.29). The age-standardized incidence rate by Chinese standard population (ASR) was 3.35/100,000, with ranking at 7th among all cancers. Pancreatic cancer incidence rate was 8.19/100,000 in urban areas whereas it was 5.41/100 000 in rural areas. Cancer mortality rate in all cancer registry areas was 6.61/100,000 (males 7.45; females 5.75), with ranking at 6th among all cancers, and 7.42/100 000 in urban but 4.94/100000 in rural areas. CONCLUSIONS: Pancreatic cancer incidence and mortality rates have shown a gradual increase in China. Owing to the difficulty of early diagnosis, identification of high-risk population and modification of risk factors are important to reduce the burden of pancreatic cancer.
OBJECTIVE: To estimate the incidence and mortality rates for pancreatic cancer in China. METHODS: After checking and reviewing the cancer registry data in 2009 from 72 cancer registry centers, we divided cancer registry areas into urban and rural areas. Incidence/mortality rates, age-specific incidence/mortality rates, age- standardized incidence/mortality rates, proportions, and cumulative incidence/mortality rates for pancreatic cancer were calculated. RESULTS: The total number of newly diagnosed pancreatic cancer cases and deaths in 2009 were 6,220 and 5,650, respectively. The crude incidence rate in all cancer registry areas was 7.28/100,000 (males 8.24, females 6.29). The age-standardized incidence rate by Chinese standard population (ASR) was 3.35/100,000, with ranking at 7th among all cancers. Pancreatic cancer incidence rate was 8.19/100,000 in urban areas whereas it was 5.41/100 000 in rural areas. Cancer mortality rate in all cancer registry areas was 6.61/100,000 (males 7.45; females 5.75), with ranking at 6th among all cancers, and 7.42/100 000 in urban but 4.94/100000 in rural areas. CONCLUSIONS:Pancreatic cancer incidence and mortality rates have shown a gradual increase in China. Owing to the difficulty of early diagnosis, identification of high-risk population and modification of risk factors are important to reduce the burden of pancreatic cancer.
Authors: Margaret Wahutu; Sara K Vesely; Janis Campbell; Anne Pate; Alicia L Salvatore; Amanda E Janitz Journal: J Okla State Med Assoc Date: 2016 Jul-Aug
Authors: Jie Chen; Linli Chen; Jianping Yu; Yanmei Xu; Xiaohui Wang; Ziqian Zeng; Ning Liu; Fan Xu; Shu Yang Journal: Mol Med Rep Date: 2018-11-09 Impact factor: 2.952
Authors: Mohamed M Gad; Mihnea-Alexandru Găman; Anas M Saad; Muneer J Al-Husseini; Omar A Shehata; Mohannad Abou Saleh; Alfred D Nelson; Carlos Roberto Simons-Linares Journal: Ann Gastroenterol Date: 2020-02-12